Several growth factor/hormone signaling pathways that are associated with cancer including fibroblast growth factor (FGF), epidermal growth factor (EGF) and insulin can modulate IRS-1 and IRS-2 expression levels [86,111-113]. The gene discussed is IRS1; the disease is cancer.